We are live on ! Find out more
GFP

Gryphon Financial Partners Portfolio holdings

AUM $1.13B
1-Year Est. Return 30.28%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+30.28%
3 Year Est. Return
+93.72%
5 Year Est. Return
+108.5%
10 Year Est. Return
AUM
$935M
AUM Growth
+$57.6M
Cap. Flow
+$33.5M
Cap. Flow %
3.58%
Top 10 Hldgs %
49.31%
Holding
352
New
29
Increased
220
Reduced
53
Closed
20

Sector Composition

Rank Sector Weight
1 Technology 18.07%
2 Communication Services 8.37%
3 Financials 7.69%
4 Healthcare 7.67%
5 Consumer Discretionary 3.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRSH
176
Marsh
MRSH
$91.5B
$677K 0.07%
3,650
+446
+14% +$83.4K
VIG icon
177
Vanguard Dividend Appreciation ETF
VIG
$114B
$658K 0.07%
2,993
+1,774
+146% +$388K
NOBL icon
178
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
$654K 0.07%
12,576
+1,714
+16% +$88.6K
HCA icon
179
HCA Healthcare
HCA
$89.5B
$646K 0.07%
1,383
+227
+20% +$105K
HIG icon
180
Hartford Financial Services
HIG
$39.3B
$642K 0.07%
4,659
+215
+5% +$28.4K
IBMQ icon
181
iShares iBonds Dec 2028 Term Muni Bond ETF
IBMQ
$662M
$638K 0.07%
24,940
XLC icon
182
State Street Communication Services Select Sector SPDR ETF
XLC
$22.4B
$638K 0.07%
5,416
PHM icon
183
Pultegroup
PHM
$25.3B
$636K 0.07%
5,422
+536
+11% +$65.7K
EMR icon
184
Emerson Electric
EMR
$88.3B
$624K 0.07%
4,701
+621
+15% +$82.4K
QLTY icon
185
GMO US Quality ETF
QLTY
$5.01B
$615K 0.07%
15,999
+69
+0.4% +$2.6K
PSX icon
186
Phillips 66
PSX
$81.4B
$611K 0.07%
4,736
+429
+10% +$57.7K
SYK icon
187
Stryker
SYK
$130B
$610K 0.07%
1,737
+190
+12% +$69.2K
AZN icon
188
AstraZeneca
AZN
$250B
$608K 0.07%
3,306
+570
+21% +$100K
LEN icon
189
Lennar Class A
LEN
$21.2B
$606K 0.06%
5,897
+1,561
+36% +$189K
GILD icon
190
Gilead Sciences
GILD
$165B
$605K 0.06%
4,928
+534
+12% +$64.9K
TT icon
191
Trane Technologies
TT
$106B
$598K 0.06%
1,536
+145
+10% +$60K
CSX icon
192
CSX Corp
CSX
$93.1B
$597K 0.06%
16,464
+713
+5% +$25.5K
SHEL icon
193
Shell
SHEL
$245B
$597K 0.06%
8,119
+518
+7% +$38.2K
IVOG icon
194
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.7B
$581K 0.06%
+4,830
New +$580K
UTHR icon
195
United Therapeutics
UTHR
$23.1B
$574K 0.06%
1,179
+206
+21% +$95.9K
GSK icon
196
GSK
GSK
$106B
$571K 0.06%
11,642
+2,145
+23% +$100K
SCHW
197
Charles Schwab
SCHW
$187B
$566K 0.06%
5,668
-160
-3% -$15.2K
CSQ icon
198
Calamos Strategic Total Return Fund
CSQ
$3.35B
$556K 0.06%
+28,982
New +$552K
DY icon
199
Dycom Industries
DY
$12.3B
$554K 0.06%
1,640
+13
+0.8% +$4.1K
EMLP icon
200
First Trust North American Energy Infrastructure Fund
EMLP
$4.08B
$553K 0.06%
14,597
+112
+0.8% +$4.27K

Similar funds

Gryphon Financial Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Gryphon Financial Partners held 352 positions worth $935M, up 6.6% from $877M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Gryphon Financial Partners deployed $33.5M of net new capital in Q4 2025, opening 29 new positions and adding to 220 existing holdings. Its largest new stake was Vanguard Morningstar Growth ETF: 14,682 shares worth $1.19M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.71M trimmed.

  • Gryphon Financial Partners's largest Q4 2025 buy was Vanguard Morningstar Growth ETF: 14,682 shares worth $1.19M.
  • Gryphon Financial Partners added most to CoreWeave in Q4 2025, an estimated $3.85M increase.
  • Gryphon Financial Partners's biggest Q4 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.71M.
  • Gryphon Financial Partners fully exited Rivian in Q4 2025, selling an estimated $2.74M.
  • Gryphon Financial Partners's ten largest holdings make up 49% of its $935M portfolio in Q4 2025.
  • Gryphon Financial Partners opened 29 new positions and closed 20 in Q4 2025.
  • Gryphon Financial Partners's portfolio value rose 6.6% quarter-over-quarter to $935M.

Based on Gryphon Financial Partners's 13F filing for Q4 2025, filed 8 Jan 2026.